Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Sensitivity, specificity, inclusivity and exclusivity of the updated Aptima Combo 2 assay, which provides detection coverage of the new diagnostic-escape Chlamydia trachomatis variants

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Differences in mortality in patients undergoing surgery for infective endocarditis according to age and valvular surgery

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Renal function in Ethiopian HIV-positive adults on antiretroviral treatment with and without tenofovir

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The cause of death in bacterial meningitis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Mycobacterium arosiense, an unexpected cause of osteomyelitis in a patient with sarcoidosis: a case report

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Association between vancomycin-resistant Enterococcus faecium colonization and subsequent infection: a retrospective WGS study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Aktuel kighosteepidemi - hvad skal jeg vide?

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Magnus Unemo
  • Marit Hansen
  • Ronza Hadad
  • Mirja Puolakkainen
  • Henrik Westh
  • Kaisu Rantakokko-Jalava
  • Carina Thilesen
  • Michelle J Cole
  • Iryna Boiko
  • Pham T Lan
  • Daniel Golparian
  • Shin Ito
  • Martin Sundqvist
View graph of relations

BACKGROUND: Four new variants of Chlamydia trachomatis (nvCTs), detected in several countries, cause false-negative or equivocal results using the Aptima Combo 2 assay (AC2; Hologic). We evaluated the clinical sensitivity and specificity, as well as the analytical inclusivity and exclusivity of the updated AC2 for the detection of CT and Neisseria gonorrhoeae (NG) on the automated Panther system (Hologic).

METHODS: We examined 1004 clinical AC2 samples and 225 analytical samples spiked with phenotypically and/or genetically diverse NG and CT strains, and other potentially cross-reacting microbial species. The clinical AC2 samples included CT wild type (WT)-positive (n = 488), all four described AC2 diagnostic-escape nvCTs (n = 170), NG-positive (n = 214), and CT/NG-negative (n = 202) specimens.

RESULTS: All nvCT-positive samples (100%) and 486 (99.6%) of the CT WT-positive samples were positive in the updated AC2. All NG-positive, CT/NG-negative, Trichomonas vaginalis (TV)-positive, bacterial vaginosis-positive, and Candida-positive AC2 specimens gave correct results. The clinical sensitivity and specificity of the updated AC2 for CT detection was 99.7 and 100%, respectively, and for NG detection was 100% for both. Examining spiked samples, the analytical inclusivity and exclusivity were 100%, i.e., in clinically relevant concentrations of spiked microbe.

CONCLUSIONS: The updated AC2, including two CT targets and one NG target, showed a high sensitivity, specificity, inclusivity and exclusivity for the detection of CT WT, nvCTs, and NG. The updated AC2 on the fully automated Panther system offers a simple, rapid, high-throughput, sensitive, and specific diagnosis of CT and NG, which can easily be combined with detection of Mycoplasma genitalium and TV.

Original languageEnglish
Article number419
JournalBMC Infectious Diseases
Volume20
Issue number1
Pages (from-to)1-6
Number of pages6
ISSN1471-2334
DOIs
Publication statusPublished - 16 Jun 2020

    Research areas

  • 23S rRNA, Aptima combo 2, Chlamydia trachomatis, Finnish new variant, Surveillance, Validation

ID: 60095952